| Sterile protection against human malaria by chemoattenuated PfSPZ vaccine B Mordmüller, G Surat, H Lagler, S Chakravarty, AS Ishizuka, ... Nature 542 (7642), 445-449, 2017 | 431 | 2017 |
| In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity GM Lynn, R Laga, PA Darrah, AS Ishizuka, AJ Balaci, AE Dulcey, ... Nature biotechnology 33 (11), 1201-1210, 2015 | 420 | 2015 |
| Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization KD Brune, DB Leneghan, IJ Brian, AS Ishizuka, MF Bachmann, SJ Draper, ... Scientific reports 6 (1), 19234, 2016 | 403 | 2016 |
| Protection against malaria at 1 year and immune correlates following PfSPZ vaccination AS Ishizuka, KE Lyke, A DeZure, AA Berry, TL Richie, FH Mendoza, ... Nature medicine 22 (6), 614-623, 2016 | 377 | 2016 |
| Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection KE Lyke, AS Ishizuka, AA Berry, S Chakravarty, A DeZure, ME Enama, ... Proceedings of the National Academy of Sciences 114 (10), 2711-2716, 2017 | 263 | 2017 |
| Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens GM Lynn, C Sedlik, F Baharom, Y Zhu, RA Ramirez-Valdez, VL Coble, ... Nature biotechnology 38 (3), 320-332, 2020 | 254 | 2020 |
| Safety, immunogenicity, and protective efficacy against controlled human malaria infection of Plasmodium falciparum sporozoite vaccine in Tanzanian adults SA Jongo, SA Shekalaghe, LWP Church, AJ Ruben, T Schindler, ... The American journal of tropical medicine and hygiene 99 (2), 338, 2018 | 140 | 2018 |
| Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions RO Payne, SE Silk, SC Elias, K Miura, A Diouf, F Galaway, H De Graaf, ... JCI insight 2 (21), 2017 | 140 | 2017 |
| Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells F Baharom, RA Ramirez-Valdez, KKS Tobin, H Yamane, CA Dutertre, ... Nature immunology 22 (1), 41-52, 2021 | 134 | 2021 |
| Systemic vaccination induces CD8+ T cells and remodels the tumor microenvironment F Baharom, RA Ramirez-Valdez, A Khalilnezhad, S Khalilnezhad, ... Cell 185 (23), 4317-4332. e15, 2022 | 80 | 2022 |
| Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance SK Totsch, C Schlappi, KD Kang, AS Ishizuka, GM Lynn, B Fox, ... Oncogene 38 (34), 6159-6171, 2019 | 58 | 2019 |
| Impact of polymer-TLR-7/8 agonist (adjuvant) morphology on the potency and mechanism of CD8 T cell induction GM Lynn, P Chytil, JR Francica, A Lagová, G Kueberuwa, AS Ishizuka, ... Biomacromolecules 20 (2), 854-870, 2019 | 47 | 2019 |
| Humoral protection against mosquito bite-transmitted Plasmodium falciparum infection in humanized mice BK Sack, SA Mikolajczak, M Fishbaugher, AM Vaughan, EL Flannery, ... npj Vaccines 2 (1), 27, 2017 | 43 | 2017 |
| Bystander responses impact accurate detection of murine and human antigen-specific CD8+ T cells MD Martin, IJ Jensen, AS Ishizuka, M Lefebvre, Q Shan, HH Xue, JT Harty, ... The Journal of clinical investigation 129 (9), 3894-3908, 2019 | 24 | 2019 |
| Identification of novel pre-erythrocytic malaria antigen candidates for combination vaccines with circumsporozoite protein C Speake, A Pichugin, T Sahu, V Malkov, R Morrison, Y Pei, L Juompan, ... PloS one 11 (7), e0159449, 2016 | 20 | 2016 |
| Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies HE Olsen, GM Lynn, PA Valdes, CD Cerecedo Lopez, AS Ishizuka, ... Neuro-Oncology Advances 3 (1), vdab027, 2021 | 18 | 2021 |
| Intravenous heterologous prime-boost vaccination activates innate and adaptive immunity to promote tumor regression RA Ramirez-Valdez, F Baharom, A Khalilnezhad, SC Fussell, ... Cell reports 42 (6), 2023 | 5 | 2023 |
| Antigenic competition affects the magnitude and breadth of CD8 T cell immunity following immunization with a nanoparticle neoantigen cancer vaccine NJ Blobel, A Ramirez-Valdez, AS Ishizuka, GM Lynn, RA Seder The Journal of Immunology 198 (1_Supplement), 73.20-73.20, 2017 | 5 | 2017 |
| Plasmodium 18S rRNA of intravenously administered sporozoites does not persist in peripheral blood SC Murphy, AS Ishizuka, ZP Billman, TM Olsen, AM Seilie, M Chang, ... Malaria Journal 17, 1-7, 2018 | 4 | 2018 |
| Structural basis for self-discrimination by neoantigen-specific TCRs JP Finnigan, JH Newman, Y Patskovsky, L Patskovska, AS Ishizuka, ... Nature Communications 15 (1), 2140, 2024 | 2 | 2024 |
Geoffrey M LynnAvidea Technologies在 jhu.edu 的电子邮件经过验证
